Livac Pty Ltd has announced the appointment of MediFocus Co. Ltd as exclusive distributor of its surgical device technology in South Korea with the company already placing an initial sales order.
Livac Pty Ltd CEO, Dr Anabela Correia, shares her insights into working with distribution partners to achieve success and grow into new markets.
The path to technology commercialisation is one that is well-documented and well-worn: unmet need leads to an idea, proof of concept built, asset protected, business plan developed, funding obtained, strategic partnerships formed, and the branded product is launched into market. These days anyone with the right idea and the right guidance can become an entrepreneur.
There was a hive of activity at the exhibition booth shared by Livac & B.Braun at the 5th Asian Congress of Robotic and Laparoscopic Surgery in Singapore.
Our CEO, Dr Anabela Correia, was delighted to return to the Australian Technologies Competition, this time as part of an entrepreneur’s panel discussion.
Article by Louise Weihart – mergermarket, Sept 2019
Livac, a privately held Melbourne-based Australian developer of devices to support minimally invasive surgery (MIS), is actively seeking AUD 6m (USD 4m) from new investors to support US market entry, said CEO Anabela Correira.
Livac Pty Ltd, an Australian medical device company, after having completed all necessary regulatory requirements of the US Food and Drug Administration, can now proceed with supply of their organ retraction system “the LiVac™ Retractor System” in the US market.